Velocity, Processivity, and Individual Steps of Single Myosin V Molecules in Live Cells  by Pierobon, Paolo et al.
4268 Biophysical Journal Volume 96 May 2009 4268–4275Velocity, Processivity, and Individual Steps of Single Myosin V Molecules in
Live Cells
Paolo Pierobon,† Sarra Achouri,† Se´bastien Courty,‡ Alexander R. Dunn,§ James A. Spudich,§ Maxime Dahan,‡*
and Giovanni Cappello†*
†Institut Curie, Centre de Recherche, Laboratoire Physico-Chimie Curie, Centre National de la Recherche Scientiﬁque, UMR 168, Universite´
Pierre et Marie Curie-Paris, Paris, France; ‡Laboratoire Kastler Brossel, Centre National de la Recherche Scientiﬁque, UMR 8552, and Physics
and Biology Department, Ecole Normale Supe´rieure, Universite´ Pierre et Marie Curie-Paris, Paris, France; and §Stanford University School of
Medicine, Stanford, California
ABSTRACT We report the tracking of single myosin V molecules in their natural environment, the cell. Myosin V molecules,
labeled with quantum dots, are introduced into the cytoplasm of living HeLa cells and their motion is recorded at the single mole-
cule level with high spatial and temporal resolution. We perform an intracellular measurement of key parameters of this molecular
transporter: velocity, processivity, step size, and dwell time. Our experiments bridge the gap between in vitro single molecule
assays and the indirect measurements of the motor features deduced from the tracking of organelles in live cells.doi: 10.1016/j.bpj.2009.02.045INTRODUCTION
Myosin V is an actin-associated protein, involved in intracel-
lular transport. This molecular motor uses the chemical
energy released during adenosine triphosphate (ATP) hydro-
lysis to produce mechanical work and to carry cargoes
through the cytoplasm. The mechano-chemical properties of
myosin V have been addressed in great detail by means of
several in vitro assays, which allow a fine and independent
control of all the parameters (ATP and adenosine diphosphate
(ADP) concentration, temperature, force and others) (1), and
structural analysis (2–4). Those experiments have shown that
myosin V molecules move by taking many consecutive steps
in a hand-over-hand manner (5). A combination of single-
molecule, optical trapping (6–17), total internal reflection
microscopy (5,18,19,20), and bulk kinetics experiments
(21–23) have contributed to determine in vitro the mecha-
nistic parameters for myosin V, notably the velocity and
length of single processive runs, under a variety of conditions.
However, the inherent limit of in vitro assays is that the
myosin V is observed out of its natural environment, the cell.
The cell is a complex machine, where the pH and the ionic
strength are actively regulated and molecular crowding is
extreme. In addition, myosin activity might depend onmolec-
ular partners, cofactors and other parameters, among which
are the local geometry and topology of the cytoskeleton. All
these elements might critically affect the motor properties
and are often difficult to reproduce in vitro.
So far, experiments aimed at characterizing the intracellular
motion of myosin V have been essentially based on the
tracking of endosomes, melanosomes, or other organelles
inside the cell (24–27). As those objects are transported by
molecular motors, the analysis of their motion provides an
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ronment. The main drawback of this approach is that neither
the type of motors pulling on a vesicle nor their total amount
is unequivocally determined. In fact, the motor family and
their number strongly affect the speed, the directionality,
and the processivity of the organelle, as well as the maximum
force developed during the motion (28).
In this work, our objective is to bridge the gap between the
in vitro characterization ofmyosin Vmotors and observations
of myosin V-driven organelle movement inside the cells. In
particular, we aim to determine whether the parameters
measured in vitro are consistent with the values measured
in vivo and quantify the differences. A clear example of
discrepancy between in vitro and in vivo is the speed of the
myosinV.While in vitro experiments provide amean velocity
in the range 200–450 nm/s (9,11,22), the tracking of organ-
elles suggests that the myosin V moves at 1 mm/s or faster
(24,29). So far, the reason for this discrepancy has remained
unclear. It could, for instance, result from a lack of optimiza-
tion of the in vitro conditions or from insufficient knowledge
on the organelles. Another key parameter that can be unequiv-
ocally determined only for a single molecule and cannot be
deduced from organelles trajectories is the processivity.
Measuring the run lengths of single myosin V molecules
inside the cell is in fact the only way to access the real
in vivo processivity of this motor.
Here we demonstrate an intracellular single-molecule
assay, in which individual myosin V motors are introduced
into cultured HeLa cells. To track the motion of these myosin
Vmolecules within the cell, we label the motor with a fluores-
cent reporter. The choice of the reporter is critical: an ideal
probe specifically binds to the myosin V without perturbing
its activity and is not cytotoxic. In addition, it should be bright
and photostable enough to allow fast detection (in the milli-
second range) and long observations (up to several minutes).
Recent works have shown that semiconductor quantum dots
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(30–33) as they satisfy most of those requirements. In our
experiments, we label the myosin V by randomly replacing
one of the 12 calmodulins with a biotinylated one (see
Fig. 2 A) and we use this biotin tag to conjugate the proteins
with streptavidin-coated QDs (34) before internalizing the
motors into the cytoplasm. Thereby, we directly measure
the velocity, processivity, and individual steps of single
myosin V molecules moving in the cytoplasm of live cells.
MATERIALS AND METHODS
In vitro motility assay
We use commercial rabbit muscle G-actin (Cytoskeleton) diluted at
2.5 mg/mL. The polymerization is induced by mixing 2 mL of G-actin and
2 mL of ATP (6 mM) in 7.5 mL of Assay Buffer (25 mM imidazole-HCl at
pH 7.4, 25 mM KCl, 1 mM EGTA, 10 mM DTT, and 4 mM MgCl2) and
incubating 20 min. The F-actin so obtained is stabilized with Alexa Fluor
488 phalloidin (2 mL at 66 mM). The stabilized actin filaments are diluted at
1:100 in assay buffer and introduced in a flow chamber where they bind to
the coverslip via myosin II treated with N-ethylmaleimide to inhibit the
ATPase site. The chamber is rinsed with Assay Buffer supplemented with
1 mg/mL of bovine serum albumin to prevent nonspecific interaction. Finally
the myosin V/Quantum dot constructs (MyoV::QDs) are introduced in the
motility buffer (final dilution 10 nM), that, in addition to the assay buffer,
contains 2 mM ATP, an oxygen-scavenging system (20 mM D-glucose,
20 mg/mL glucose-oxydase, 8 mg/mL catalase) and ATP regeneration system(40mMphospho-creatine and 0.1mg/mL creatine-phosphokinase, following
the protocol in (35)). The coverslip is sealed with vaseline, lanoline, and
paraffin at 1:1:1. Observations are performed at room temperature (23C).
Myosin and calmodulin preparation
The chicken myosin V/GCN4 fusion plus calmodulin is expressed and puri-
fied as previously described (19,36), with minor modifications. The human
essential light chain LC1sa is cloned into the pFastBac vector and converted
into a separate virus. Coinfection with the myosin V/calmodulin virus and
the LC1sa virus leads to the expression of myosin V bearing both calmod-
ulin and the essential light chain.
A single cysteine is incorporated into sea urchin vertebrate-like calmod-
ulin via the mutation Q143C, and the protein is expressed and purified as
previously described (19). Q143C calmodulin is transferred into buffer con-
taining 20 mM imidazole and 5 mM CaCl2, pH 7.5 using a Micro Bio-Spin
6 buffer exchange column (BioRad, Hercules, CA), and diluted to a final
protein concentration of 6.7 mg/mL. Biotin-maleimide (Sigma, St. Louis,
MO) is prepared as a 50-mM stock solution in dimethylsulfoxide, and added
to a final concentration of 0.5 mM. The reaction is then incubated at room
temperature for 1 h, then dialyzed against 10 mM imidazole, 0.5 mM
EGTA, and 0.5 mM DTT, pH 7.5 overnight at 4C. Biotinylation is
confirmed by MALDI-mass spectroscopy. Aliquots are flash-frozen and
stored at 80C.
Construction of the myosin V/calmodulin
SeeDunn and Spudich (34). Biotinylated calmodulin is attached to theMyoV
following an established protocol, which yields at most one labeled calmod-
ulin per dimer. One microliter of biotinylated calmodulin is diluted in 3 mL ofFIGURE 1 (A) Cartoon of the myosin V on an actin fila-
ment. A quantum dot (QD) is attached to one of the IQ
domains of the myosin leg. (B–F) Results of the in vitro
experiments: (B) typical steplike trajectory of a single motor
running on an actin filament at [ATP] ¼ 500 nM; (C) step-
like curves at [ATP] ¼ 2 mM; step-size distribution (D),
velocity (E) and processivity (F) of myosin V in vitro at
[ATP] ¼ 2mM and low illumination power.
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FIGURE 2 (A) Three optical sections
of a HeLa cell after MyoV::QD internal-
ization. The actin filaments are marked
with phalloidin Alexa Fluor 488, while
the myosin V is marked with the QDs
emitting at 605 nm. The cells are fixed
90 min after the end of the pinocytosis
and observed with a spinning disk
confocal microscope equipped with
a 60 NA 1.4 oil immersion objective.
The Alexa Fluor 488 is excited with
491-nm laser and the QDs with
a 561-nm laser. The picture shows that
most of theQDs are inside the cytoplasm
and do not form aggregates. (B and C)
Trajectories of a quantum dot moving
in a HeLa cell. The sequence of frames
is extracted from a movie acquired at
200 frames per s. The scale is 500 nm
in both sequences. The quantum dot in
the panel B sequence is attached to
a myosin V and moves along an actin
filaments while the one in panel
C randomly diffuses through the cyto-
plasm; QD positions are extracted fitting
the point-spread function to a two-
dimensional Gaussian with a spatial
precision of 10-nm (trajectories in
green). Directed motions are often curvilinear due to the flexibility of the actin filaments and are therefore fit to a polynomial curve (right line on the top). (Right)
Mean-square displacement measurements allow us to discriminate between the one dimension diffusion and progressive motion. (Red line) Quadratic (linear)
fit of the MSD of the direct (diffusive) trajectory.Exchange Buffer (EB, 25 mM KCl, 25 mM imidazole, and 4 mM MgCl2,
pH 7.5). One microliter of this dilution and 1 mL ofMyoV are added to 18 mL
of EB and incubated at room temperature for 2 min. Addition of 1 mM of
CaCl2 initiates the calmodulin exchange, which is quenched by addition of
8 mM of EGTA after 5 min at room temperature. QD-streptavidin conjugates
are purchased from Invitrogen (Carlsbad, CA). The particles are diluted from
2 mM to 100 nM in their buffer (borate buffer) and sonicated twice for 15 s.
Four microliters to 16 mL of this dilution and 4 mL of taggedMyoV are added
to EB to obtain 40 mL of conjugated MyoV::QD. Steps are observed only
when the ratio QD/MyoV is >4.
Intracellular loading of MyoV::QD
See Courty et al. (30) and Okada and Rechsteiner (37). Cell cultures on
30-mm glass coverslips are immersed in the hypertonic medium (94%
D-MEM, 5% serum, 1% HEPES, glucose at saturating concentration) with
the MyoV::QD construction at concentration 10 nM (40 mL in 360 mL of
hypertonic medium) for 12 min, then immersed in the hypotonic medium
(60% D-MEM-serum, 40% water MQ) for 2 min and kept in the recovery
medium (90% Opti-MEM, 10% serum) for the rest of the observation time.
Data collection and analysis
QD-tagged myosins are imaged using a wide-field epi-fluorescence micro-
scope (Axiovert 100, oil objective 100, NA 1.40 plus a 2.5 magnifying
lens; Carl Zeiss, Oberkochen, Germany) and an amplified CCD camera iXon
EMDU860-BV (CCD size 128 128 pixels, pixel size 24 mm; Andor Tech-
nology, South Windsor, CT). The QDs (emitting at 605 nm) are excited at
532 nm with a laser spot of 15 mm in diameter and intensity 1–4 kW/cm2.
The processivity and the velocity in vitro are measured at lower illumination
intensity (~300 W/cm2) to reduce the blinking of the QDs.
Individual trajectories are extracted from image sequences by means of
a homemade particle-tracking program implemented in MatLab (TheBiophysical Journal 96(10) 4268–4275MathWorks, Natick, MA). After the operator has introduced manually the
initial point, the position of a MyoV::QD is determined in each frame by
fitting the fluorescent spot with a two-dimensional Gaussian (5,38). The
results of the fit are taken as initial conditions for the fit in the following
image. In the case of blinking, the program tries to retrace the nanoparticle
in the 10 subsequent frames. If the blinking duration exceeds 10 frames, the
fitting is stopped and the results analyzed. We use a time resolution of 5 ms,
which gives, in vitro, a pointing accuracy of ~10 nm. This localization accu-
racy, estimated using immobilized QDs, is mainly limited by the total
amount of photons supplied by the QD. Stronger illumination and/or longer
exposure time would, in principle, improve the tracking precision. However,
long exposure times partially hide the myosin stepping while stronger illu-
mination enhances the QD blinking and makes the tracking more difficult.
As the trajectories are often curved, we introduce a curvilinear abscissa to
describe the motion of the MyoV::QD. To estimate the analytical expression
of the whole trajectory, we fit the position of the center at each time step
(x(t), y(t)) with two independent polynomials (function of time) of nth degree:
xðtÞ ¼ a0 þ a1t þ a2t2 þ.þ antn and yðtÞ ¼ b0 þ b1t þ b2t2 þ.þ bntn.
The degree of the polynomials is usually fixed to three but in some cases
has to be increased, in particular when the trajectories are very long (see
Supporting Material). The trajectories are then projected along the curvilinear
abscissa.
Fixation of the cells
Cells are fixed 90 min after QD internalization with a pynocitic influx. The
cells are then rinsed with phosphate-buffered saline (PBS) and fixed with 4%
paraformaldehyde diluted at 4% for 10 min. The cells are rinsed three times
every 5 min with PBS. We subsequently stain the actin filaments incubating
the cells 30 min in PBS with bovine serum albumin at 0.1% and fluorescent
phalloidin Alexa Fluor 488 at 0.5 mM. Finally, we rinse the cells with PBS
every 5 min and mount them on a glass coverslip using Vectashield (Vector
Laboratories, Burlingame, CA).
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We first verify the activity of the MyoV::QD constructs and
check the accuracy and reproducibility of our assays. We
perform in vitro experiments in the bead-assay geometry,
with a QD instead of a bead (see Materials and Methods)
(18). To determine the experimental conditions to observe a
single-molecule run, we progressively reduce the MyoV/QD
ratio, until the myosin stepping becomes visible, as shown in
Fig. 1, B and C. We define as single-molecule measurement
the experiments carried out with this MyoV/QD relative
concentration. The experiments are performed with ATP
concentrations of 500 nM and 2 mM. At 500 nM ATP, the
stepping rate is mainly limited by the ATP on-rate, and the
average dwell time, i.e., the mean interval between consecu-
tive steps, is ~4 s (22). At 2 mM ATP, a value close to the
physiological concentration, the stepping rate is limited by
the ADP release and the dwell time drops to ~160 ms (23).
In both ATP conditions, individual steps of the motor are
clearly identified (Fig. 1, B and C).
The step sizes and durations are extracted from the trajecto-
ries by means of a step-finding algorithm (red line in Fig. 1, B
andC) (39). In many trajectories, we measure an average step
size of ~74 nm, which corresponds to the typical distance
covered by the myosin V head, labeled with a QD, during
the step. We also observe sequences of alternate 30 nm and
40 nm steps (see Fig. 1 D). As already mentioned in the liter-
ature, such shorter steps result from QDs attached higher up
on the lever arm, close to themyosin stalk.We did not observe
alternate 20-nm and 50-nm steps, as reported elsewhere
(5,34). Since we are interested in comparing the results of
in vitro assays with observations in living cells, we determine
the velocity and processivity of the myosin V at 2 mM ATP
(Fig. 1, E and F). We find an average run length ( standard
error of the mean) of 1.3  0.2 mm (n ¼ 90) and an average
velocity of 500  30 nm/s (n ¼ 90). All these results are in
agreement with the literature (5,11,40) and in particular
with the measurements made on the same motor tagged
with a gold nanoparticle (diameter ~40 nm) (34).
Having demonstrated that the motor protein remains active
after QD conjugation and behaves as a single molecule, we
focus on experiments in living cells. To ensure a significant
comparison between in vitro assays and observations in living
cells, both kinds of experiments are carried out in parallel,
using the same batch of MyoV::QD and at the same tempera-
ture (23C). The internalization within cells is achieved
through osmotic release of pinocytic vesicles (see Materials
and Methods), which leads to the uptake of the MyoV::QD
by the cells in ~15 min (30). After the pinocytic influx, we
let the cells recover for 1 h in the incubator at 37C. The
dynamics of MyoV::QD constructs in the cells is then
recorded at room temperature by fluorescence video-micros-
copy. In the best cases, we observe motility for up to 5 h after
pinocytosis. Fig. 2 A shows three optical sections of a HeLa
cell after MyoV::QD internalization, fixation, and stainingof the actin filaments with fluorescent phalloidin (green fila-
ments). The images are extracted from a stack acquired with
a spinning disk microscope. We observe that most of the
MyoV::QDs (red dots) are localized in the cytoplasm and
very few remain trapped at the cellmembrane. NoMyoV::QD
are observed inside the nucleus. Eventually, we recognize
single QDs from aggregates (which are rather rare, as can
be seen from Fig. 2 A) by their characteristic blinking.
In living cells, we observe two different types of motion. A
large fraction of the MyoV::QD freely diffuse in the cyto-
plasm, while ~5% of them exhibit a direct motion. We inter-
pret the latter events asMyoV::QD running on actin filaments
and the former as due to unbound MyoV::QD or unconju-
gated QDs. In Fig. 2, B and C, we show two sequences
of images, which illustrate the typical movements. The
MyoV::QD in Fig. 2B exhibits a directedmovement, possibly
along an actin filament. As many trajectories occur on actin
filaments bent at the micrometer scale, we project the x,y
coordinates of the MyoV::QD position on a curvilinear
abscissa (red curve in Fig. 2 B), as detailed in the Materials
and Methods. In contrast, the MyoV::QD in the sequence
of Fig. 2 C seems to randomly diffuse in the cytoplasm. To
further analyze the motion, the mean-square displacement
(MSD) is computed for both trajectories (last column of
Fig. 2, B and C). The MSD for the MyoV::QD above varies
quadratically, indicative of a directional movement with an
average speed y ¼ 390  10 nm/s. The MSD for the
MyoV::QD below is linear, corresponding to a Brownian
diffusion with a coefficient D ¼ 9.8  0.1  103 mm2/s.
The average diffusion constant measured in the cells with
our construct is D ¼ 1.8  0.7  102 mm2/s) (n ¼ 10).
We verify that the directed motions are due to the activity
of myosin V. To do so, we perform three control experiments
in which we internalized:
1. Nonconjugated QDs.
2. QDs coupled with biotinylated calmodulin only.
3. QDs coupled with denaturated myosin V (kept for 2 h
at 23C).
In none of those control experiments do we observe
directed motions. This rules out the possibility that the
MyoV::QD are trapped in pinosomes, endosomes, or other
organelles transiently carried by endogenous motors (e.g.,
myosin, kinesin, or dynein). Therefore, we consider that
the myosin V is responsible for the MyoV::QD motion. In
light of recent experiments by Ali et al. (41), showing that
myosin V can diffuse on microtubules, we investigate the
role of the microtubules on MyoV::QD movement. Upon
incubation of the cells with microtubule-depolymerizing
drug nocodazole (10 mM), we still observe directed move-
ment of the MyoV::QD, with an average velocity of 630 
100 nm/s, close to the one measured in the untreated cells.
This rules out the hypothesis that the motion inside the cell
originates from a coupling with the microtubules network.
To further verify that the motion, we observe results fromBiophysical Journal 96(10) 4268–4275
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the cells with 1 mM Latrunculin A for 30 min. No directed
motion is observed in these treated cells. Motility is recov-
ered ~1 h after washing Latrunculin A from the medium.
In the following, we focus on the MyoV::QD exhibiting
a directed motion. In approximately one-third of the trajecto-
ries, we distinguish steps in the motion of the MyoV::QD, as
shown in the Fig. 3 A. We notice that intracellular tracks
exhibit more fluctuations compared to in vitro traces. Several
factors possibly account for this additional noise. In cells, the
signal/noise ratio in the detection of a single QD is reduced
due to the autofluorescence background, leading to a
degraded pointing accuracy. In addition, actin filament
fluctuations, as well as cell intrinsic motion, might contribute
to the noise in the MyoV::QD position and spread the exper-
imental measurements.
The step-size distribution is represented by the histogram
in Fig. 3 B, from which we compute an average step size of
74  2 nm (n ¼ 412). The associated dwell-time distribution
FIGURE 3 Results of the experiments in living cells. (A) Examples of
the steplike curves observed in the cells (in red is the fit performed with
the step-finding algorithm). (B) Step-size and (C) dwell-time distributions.
(D) Velocity and (E) processivity of the motors.Biophysical Journal 96(10) 4268–4275is shown in the Fig. 3 C. The mean dwell time, computed on
412 events, is 80  5 ms. From our data, we also extract the
velocity and the processivity. Fig. 3 D shows the speed
distribution for 92 tracks, which gives an average value of
710  50 nm/s (n ¼ 92). The processivity distribution is
shown in Fig. 3 E and is characterized by an average value
of 2.2  0.2 mm (n ¼ 92).
DISCUSSION
General remarks
In our experiments, we develop an assay to investigate the
properties of individual myosin V motors in live cells. First,
purified myosin V molecules are labeled in vitro. We next
verify their functionality after conjugation with a QD. Finally
we prove that themotor activity ismaintained once introduced
in the cytoplasm. In this work, we measure the step size, the
dwell-time, the processivity, and the velocity of the myosin
V in the cell. Before commenting on the distributions of these
different observables, we make some general remarks on our
assay.
One could argue that QDs, which have a hydrodynamic
diameter at ~30 nm (42), are a probe sufficiently large to
significantly affect the motion of the myosin V. We compare
the maximal force developed by the myosin V to the viscous
drag of aQD carried through the cytoplasm. The viscous force
acting on the QD is F ¼ kBTD y, where D is the diffusion
constant, kB the Boltzmann constant, T the temperature, and
y the speed imposed by the myosin V. Given a diffusion
coefficient of D ¼ 1.8  0.7  102 mm2/s and a velocity
y ¼ 710 nm/s, the viscous force is ~0.16 pN. This force is
10-times smaller than the stall force of the myosin V (~2 pN)
(11), and therefore, should not perturb the myosin motion.
A second remark concerns the three-dimensional motion of
the myosin V. In principle, a correction should be applied to
the trajectories that are not parallel to the focal plane.
However,when aQDmoves out of focus, thewidth of its fluo-
rescence spot increases. Here we discard trajectories where
this broadening is observed. For the trajectories that remain
within the depth of field, a simple estimate shows that the
effect of three-dimensional movement on the velocity or
step-size measurements is minimal. Indeed, if we consider
a depth of field of ~500 nm and an average run length of
2mm, themaximum tilt qm of the trajectory is ~15
. Assuming
an homogeneous distribution of tilt between qm and þ qm,
this implies that the processivity, velocity, and step-size are
underestimated by no more than 2%, well below our experi-
mental uncertainty. Moreover, the HeLa cells are rather flat
(aspect ratio 20:1) and it is much more likely to observe a
nearly flat trajectory than a tilted one.
Step size and dwell time
As explained above, the step size and dwell time are
extracted from the steplike curves similar to the ones showed
Myosin V Molecules in Live Cells 4273in Figs. 1 and 3. For the analysis, we focus only on the curves
where the steps can be visually identified. As a result, we
end up with 28 curves (for a total of 412 steps) out of the
92 tracks measured in the cells. We also consider as fake
the steps smaller than 10 nm and shorter than 10 ms, because
they fall below our experimental resolution. The step-size
distribution is shown in Fig. 3 B. The mean value of the
step size, computed from 412 single steps, is 74  2 nm.
This value coincides exactly with the one expected for
a myosin V labeled with QD attached near the head.
Actually, this finding is a little surprising given that the
distribution results from the superposition of different
subpopulations of steps. In addition to motors moving
with 74-nm steps, there are also those with alternate 30-
and 40-nm steps (or 20- and 50-nm) (5). In contrast to
in vitro experiments, our spatial resolution in cells does
not permit us to unambiguously distinguish the different
kinds of tracks. This partly accounts for the broadening
of the distribution.
Another effect also contributes to the width of the distribu-
tion and, in particular, to the observation of large steps
(>74 nm). As further discussed below, the velocity of the
motor in the cell is ~700 nm/s, faster than in vitro. For
a 36-nm step, this corresponds to a dwell time of 50 ms. In
our measurements (Fig. 3 C), we found a mean dwell time
of T ¼ 40  5 ms (n ¼ 412), in reasonable agreement
with the expected value. As a result, there is an increased
probability of missing single steps. Indeed, when two or
more steps occur within 15 ms (three frames), they appear
as a single, larger one. The percentage of steps experimen-
tally missed can be evaluated using Poisson statistics.
The probabilities Pn¼2 and Pn¼3 of having two and three
consecutive 36-nm steps within an interval of duration t,
conditionally on the fact that one step occurred, are equal to
a/2 and a2/6, respectively (with a ¼ t/T). For t ¼ 15 ms
and T ¼ 40 ms, Pn¼2 z 18% and Pn¼3 z 2%, meaning
that the probability of measuring multiple steps exceeds
20%. A more detailed investigation of myosin V stepping
needs higher spatial and temporal resolution. This might
require other imaging techniques, probably based on light
scattering (43) rather than on fluorescence.
Processivity and velocity
In vitro we find a mean spatial processivity of 1.3  0.2 mm,
while it is slightly longer in the cells where the mean value is
2.2  0.2 mm. Both are compatible with the ones reported in
the literature (see Table 1). The discrepancy between run
length in vitro and intracellularly might be due to the QD
blinking that artificially shortens the apparent run length
in vitro. In fact, the experiments in vitro that we perform at
higher illumination power systematically show shorter proc-
essivity. The effect is much weaker inside the cells, where
the blinking is noticeably lower, possibly due to the reducing
environment in the cytoplasm (32). Alternatively, we mightargue that this processivity difference is due to the effect of
local viscosity. We can define as the escape time the time
tesc needed to diffuse away from the filament over a distance
comparable with the myosin length (i.e., 36 nm). In pure
water, tesc is ~30 ms for a 30 nm QD. This value is much
shorter than the typical binding time of the myosin V head
(0.5–2.0 ms (8,34)). As a consequence, when the myosin V
releases from the actin filament, the chance of escaping is
much higher than rebinding. On the contrary, in the cytoplasm
the diffusion coefficient of the QD is reduced by a factor of
~1000, which implies a tesc in the tens of milliseconds range.
In that case, when the myosin V unbinds from the actin fila-
ment its diffusion is basically limited by the QD diffusion.
Thus, themyosinVhas a chance to rebind to the actin filament
and to increase its apparent processivity. Both in vitro and in
the cells, we notice a correlation between the MyoV/QD ratio
and the processivity: as expected, QDs with more than one
myosin V run over longer distances before unbinding (see
Movie S1, Movie S2, andMovie S3, in SupportingMaterial).
Our in vitro velocity is among the highest measured in the
literature (i.e., x400 nm/s on reconstituted actin filaments
suspended between two beads (10), see Table 1). In the cells,
the myosin V velocity is slightly higher than in vitro (see
Fig. 4 for a comparison, through the cumulative distribu-
tions, between in vitro and intracellular velocities). This
observation seems counterintuitive, because the cellular
crowding and the other proteins bound to the actin filaments
are likely to impede the myosin motion, rather than speeding
it up (44). As a cause for the discrepancy between the veloc-
ities in vitro and in vivo, we can rule out effects like the
treadmilling of actin filaments or drift due to global contrac-
tion of the cell because both are too slow (~10 nm/s). We
cannot exclude an apparent velocity increase caused by
sliding between filaments generated by the action of cellular
myosin II. However, we suspect that this small discrepancy
may be due simply to a lack of optimization of the in vitro
single molecule assays. In fact, it is hard to faithfully repro-
duce the exact conditions (pH, salts, ATP, ADP, and Pi
concentrations) in which the proteins operate inside the
cell. This supports the need for intracellular single-molecule
TABLE 1 Comparison of the velocities and processivities
found in the literature and measured in this work
Cell Cell Cell
In vitro (vesicle) (this work) (þnocodazole)
Velocity (nm/s) 500  30 n.a. 710  50 630  100
Velocity
literature (nm/s)
200 ~450* 450 ~1800y n.a. n.a.
Processivity (mm) 1.3  0.2 n.m. 2.2  0.2 2.3  0.2
Processivity
literature (mm)
1.0 ~2.4z n.m. n.a. n.a.
Note that ‘‘n.a.’’ means that data are not available; ‘‘n.m.’’ indicates data that
are not measurable or that do not represent a meaningful observable.
*See Rief et al. (11) and Mehta et al. (11).
ySee Levi et al. (29).
zSee Yildiz et al. (5) and Vale and Milligan (40).Biophysical Journal 96(10) 4268–4275
4274 Pierobon et al.experiments, since they provide a more physiologically
relevant measurement of the myosin V activity.
Finally, we compare our results with the ones obtained in
the cell for another molecular motor: kinesin I. We previ-
ously reported (30) that, unlike the myosin V, the kinesin I
runs at the same speed in vitro and inside the cell. We also
observed that a single kinesin is able to cover, inside the
cell, a total distance of several microns, much larger than
the distance allowed by its processivity (~1 mm). A careful
analysis of the trajectories showed that these long tracks
were constituted by a sequence of directed movements, not
exceeding the normal processivity of the kinesin, followed
by short phases of Brownian diffusion. None of our experi-
ments on the myosin V shows that this molecular motor
rebinds to actin filaments shortly after release. The difference
observed in the experiments in the cells between those two
processive motors may be related to their binding affinity
to the filaments on which they run, as well as to the organi-
zation of those filaments in the cytoplasm.
CONCLUSION
We report a simple assay to observe the activity of single
myosin V in the cytoplasm of living cells. After conjugation
to a QD and internalization in the cytoplasm of live HeLa
cells, we record the myosin motion with a frame rate of
200 s–1 and high spatial resolution. Thereby, we measure
the mechanistic parameters of the myosin V in its natural
environment, including its velocity, processivity, step size,
and dwell time. Compared to in vitro measurements we
find slightly increased velocity and processivity. Our obser-
vations combine the benefits of a single molecule approach
with the complexity intrinsic to living cells and extend the
FIGURE 4 Comparisonof the velocity cumulative distributions in different
experimental conditions. (Green and red lines) Velocitiesmeasured in the cell
with and without nocodazole, respectively. (Blue line) Speed of cumulative
distribution in vitro. (Inset) Comparison of the three averages (same color
code); error bars represent the standard deviation of the distribution.Biophysical Journal 96(10) 4268–4275description of the myosin V obtained with in vitro assays.
Our approach goes beyond conventional experiments on
organelles and opens interesting perspectives for studying
intracellular transport pathways and how motors behave in
complex filament networks. To further expand the range of
applications on intracellular single-molecule experiments,
the natural following step will be to directly tag endogenous
myosin motors, possibly with an in situ conjugation.
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